慢性咳嗽的同种疗法--一项多中心、前瞻性、探索性试验

Harleen Kaur, Lex Rutten, C. Lamba, Shalini Rao, Anurag Bajpai, Jyoti Sachdeva, S. Raizada, Sujata Choudhury, Vaishali Shinde, Vinitha Er, Chittarajan Kundu, Partha Pratim Pal, R. Kiranmayee, A. Sahoo, Bodankar Rajashekhar, R. Shil, Nidhi Mahajan, Anil Khurana, Praveen Oberai, Rajkumar Manchanda
{"title":"慢性咳嗽的同种疗法--一项多中心、前瞻性、探索性试验","authors":"Harleen Kaur, Lex Rutten, C. Lamba, Shalini Rao, Anurag Bajpai, Jyoti Sachdeva, S. Raizada, Sujata Choudhury, Vaishali Shinde, Vinitha Er, Chittarajan Kundu, Partha Pratim Pal, R. Kiranmayee, A. Sahoo, Bodankar Rajashekhar, R. Shil, Nidhi Mahajan, Anil Khurana, Praveen Oberai, Rajkumar Manchanda","doi":"10.51910/ijhdr.v23icf.1304","DOIUrl":null,"url":null,"abstract":"Context \nCough is a major symptom of respiratory and some non-respiratory ailments for which patients usually seek primary medical care. Homoeopathy is frequently used for treatment of chronic cough. \nObjective \nThis study aims to assess whether homoeopathy is useful for treating chronic cough resulting from Upper airway cough syndrome (UACS), Asthma and related syndromes, or Gastroesophageal reflux disease (GERD). \nStudy Design   \nA multi‑centre, exploratory, prospective trial. \nStudy setting \nThe study was conducted in the outpatient departments of 10 centres of CCRH, India from May 2018 – June 2020. \nPatients \nPatients of any gender, between 7-65 years of age, presenting with cough lasting >8 weeks, were enrolled. \nMain Outcome Measure(s) \nCough Severity Index (CSI) and EQ-5D-5L scales were used to analyse the outcomes. \nResults \nOut of 2397 patients screened only 706 cases, with minimum four follow ups were analysed, on modified Intention to Treat (mITT) basis. CSI and EQ-5D-5L scores were used to analyse the outcomes of the study. The mean of the CSI score at baseline was 19.09 whereas it reduced to 3.89 in the eighth follow-up with p value <0.01. The mean of the EQ-5D-5L score at baseline was 50.59 which increased to 73.79 in the last follow-up, with p-value<0.05. Phosphorus, Arsenic album, Pulsatilla, Sulphur, Lycopodium and Silica were found to be the most frequently prescribed medicines.","PeriodicalId":106057,"journal":{"name":"International Journal of High Dilution Research - ISSN 1982-6206","volume":"117 34","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Homoeopathic treatment for chronic cough – a multicentric, prospective, exploratory trial\",\"authors\":\"Harleen Kaur, Lex Rutten, C. Lamba, Shalini Rao, Anurag Bajpai, Jyoti Sachdeva, S. Raizada, Sujata Choudhury, Vaishali Shinde, Vinitha Er, Chittarajan Kundu, Partha Pratim Pal, R. Kiranmayee, A. Sahoo, Bodankar Rajashekhar, R. Shil, Nidhi Mahajan, Anil Khurana, Praveen Oberai, Rajkumar Manchanda\",\"doi\":\"10.51910/ijhdr.v23icf.1304\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Context \\nCough is a major symptom of respiratory and some non-respiratory ailments for which patients usually seek primary medical care. Homoeopathy is frequently used for treatment of chronic cough. \\nObjective \\nThis study aims to assess whether homoeopathy is useful for treating chronic cough resulting from Upper airway cough syndrome (UACS), Asthma and related syndromes, or Gastroesophageal reflux disease (GERD). \\nStudy Design   \\nA multi‑centre, exploratory, prospective trial. \\nStudy setting \\nThe study was conducted in the outpatient departments of 10 centres of CCRH, India from May 2018 – June 2020. \\nPatients \\nPatients of any gender, between 7-65 years of age, presenting with cough lasting >8 weeks, were enrolled. \\nMain Outcome Measure(s) \\nCough Severity Index (CSI) and EQ-5D-5L scales were used to analyse the outcomes. \\nResults \\nOut of 2397 patients screened only 706 cases, with minimum four follow ups were analysed, on modified Intention to Treat (mITT) basis. CSI and EQ-5D-5L scores were used to analyse the outcomes of the study. The mean of the CSI score at baseline was 19.09 whereas it reduced to 3.89 in the eighth follow-up with p value <0.01. The mean of the EQ-5D-5L score at baseline was 50.59 which increased to 73.79 in the last follow-up, with p-value<0.05. Phosphorus, Arsenic album, Pulsatilla, Sulphur, Lycopodium and Silica were found to be the most frequently prescribed medicines.\",\"PeriodicalId\":106057,\"journal\":{\"name\":\"International Journal of High Dilution Research - ISSN 1982-6206\",\"volume\":\"117 34\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of High Dilution Research - ISSN 1982-6206\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.51910/ijhdr.v23icf.1304\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of High Dilution Research - ISSN 1982-6206","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51910/ijhdr.v23icf.1304","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景 咳嗽是呼吸道疾病和一些非呼吸道疾病的主要症状,患者通常会寻求初级医疗服务。同种疗法常用于治疗慢性咳嗽。本研究旨在评估同种疗法是否有助于治疗上气道咳嗽综合征(UACS)、哮喘及相关综合征或胃食管反流病(GERD)引起的慢性咳嗽。研究设计 多中心、探索性、前瞻性试验。研究地点 研究于 2018 年 5 月至 2020 年 6 月在印度 CCRH 的 10 个中心的门诊部进行。患者 患者性别不限,年龄在 7-65 岁之间,咳嗽持续时间大于 8 周。主要结果测量 采用咳嗽严重程度指数(CSI)和 EQ-5D-5L 量表分析结果。结果 在筛选出的 2397 例患者中,只有 706 例进行了至少四次随访,并根据修改后的意向治疗(mITT)进行了分析。研究结果采用 CSI 和 EQ-5D-5L 评分进行分析。基线 CSI 评分的平均值为 19.09,在第八次随访时降至 3.89,P 值小于 0.01。基线时的 EQ-5D-5L 平均值为 50.59,在最后一次随访中增至 73.79,P 值<0.05。磷、砒霜、白头翁、硫磺、莱菔子和硅石是最常用的处方药。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Homoeopathic treatment for chronic cough – a multicentric, prospective, exploratory trial
Context Cough is a major symptom of respiratory and some non-respiratory ailments for which patients usually seek primary medical care. Homoeopathy is frequently used for treatment of chronic cough. Objective This study aims to assess whether homoeopathy is useful for treating chronic cough resulting from Upper airway cough syndrome (UACS), Asthma and related syndromes, or Gastroesophageal reflux disease (GERD). Study Design   A multi‑centre, exploratory, prospective trial. Study setting The study was conducted in the outpatient departments of 10 centres of CCRH, India from May 2018 – June 2020. Patients Patients of any gender, between 7-65 years of age, presenting with cough lasting >8 weeks, were enrolled. Main Outcome Measure(s) Cough Severity Index (CSI) and EQ-5D-5L scales were used to analyse the outcomes. Results Out of 2397 patients screened only 706 cases, with minimum four follow ups were analysed, on modified Intention to Treat (mITT) basis. CSI and EQ-5D-5L scores were used to analyse the outcomes of the study. The mean of the CSI score at baseline was 19.09 whereas it reduced to 3.89 in the eighth follow-up with p value <0.01. The mean of the EQ-5D-5L score at baseline was 50.59 which increased to 73.79 in the last follow-up, with p-value<0.05. Phosphorus, Arsenic album, Pulsatilla, Sulphur, Lycopodium and Silica were found to be the most frequently prescribed medicines.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信